The pharmaceutical world is witnessing a significant shift in diabetes therapy with the arrival of GLP-1 patches. These devices offer a possibly more user-friendly alternative to subcutaneous administrations of GLP-1 receptor agonists, minimizing the need for daily needle sticks. The technology administers the medication directly through the surfac